HESTER BIOSCIENCES
Back to Cashflow Statement
|
HESTER BIOSCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹64 Cr | ₹65 Cr | ₹48 Cr | ₹24 Cr | ₹8.71 Cr |
What is the latest Cash Flow from Operating Activities ratio of HESTER BIOSCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹64 Cr |
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹48 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹8.71 Cr |
How is Cash Flow from Operating Activities of HESTER BIOSCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹64 Cr | -0.57 | |
| Mar2025 | ₹65 Cr | 33.89 | |
| Mar2024 | ₹48 Cr | 104.20 | |
| Mar2023 | ₹24 Cr | 170.84 | |
| Mar2022 | ₹8.71 Cr | - | |
Compare Cash Flow from Operating Activities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹2,055.6 Cr | -2.6% | -1.1% | 23.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -2.6% |
-1.1% |
23.6% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses